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Adipocytes play important roles in lipid metabolism but also in the control of inﬂammatory pro-
cesses. Based on our previous ﬁndings of heat shock protein (Hsp) 60-induced activation of preadi-
pocytes we investigated whether the capacity of heat shock protein 60 (Hsp60) to interact with
adipocytes and to stimulate their proinﬂammatory activity is determined by the differentiation
state of the cells. Hsp60 bound to adipocytes and stimulated the release of inﬂammatory mediators
independent of their differentiation state. Hsp60-adipocyte interactions revealed basic characteris-
tics of a receptor-mediated process. Our ﬁndings characterize Hsp60 binding and Hsp60-induced
release of proinﬂammatory mediators as fundamental properties of adipocytes independent of their
differentiation state.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Adipocytes are a population of mesenchymal-derived cells with
a close phylogenetic relationship to innate immune cells [1]. They
develop from precursor cells, the preadipocytes, which represent a
prevalent population of the stromal vascular cell fraction. Besides
their common phylogenetic origin, adipocytes and innate immune
cells share numerous functional properties such as the capacity to
release a variety of immunologically active mediators, enabling
both cell types to control the induction and progression of inﬂam-
matory processes [2,3].
In order to identify adipocyte-activating signals we recently
demonstrated efﬁcient proinﬂammatory activation of preadipo-
cytes by heat shock protein 60 (Hsp60) [4], a prominent member
of the stress protein family [5]. These ﬁndings for the ﬁrst
time identiﬁed a stress protein as an activating signal for preadi-
pocytes and further emphasized the innate immune character ofchemical Societies. Published by E
-6, interleukin-6; KC, mouse
, monocyte chemoattractant
n; PPARc, peroxisome prolif-
r-1
esseldorf.de, burkart@ddﬁ.this cell population, since responsiveness to stress signals is
regarded as an essential property of the non-adaptive immune
system [6].
The development of obesity is accompanied by the progressive
differentiation of preadipocytes to adipocytes. During this process,
the functional properties of adipocytes undergo profound changes
including alterations of the mode of triglyceride-metabolism and
-storage, the response to extracellular signals and the patterns of
secreted mediators [7]. Recent ﬁndings demonstrate an inﬂuence
of differentiation even on the responsiveness of adipocytes to
stress conditions, such as hypoxia [8]. These observations implicate
that the differentiation process also affects the responsiveness of
adipocytes to the proinﬂammatory signaling by HSP. Since mature
adipocytes constitute by far the largest adipocyte population in the
adipose tissue of obese individuals [9] it is conceivable that their
ability to respond to HSP strongly affects the levels of immunolog-
ically active mediators that sustain obesity-related, chronic inﬂam-
matory processes. However, currently, the effects of HSP on the
inﬂammatory activity of terminally differentiated adipocytes are
unknown.
Therefore, the present study was designed to investigate
whether the differentiation process affects the Hsp60 responsive-
ness of adipocytes. The investigations were performed in
adipocytes from the murine cell line 3T3-L1 and from the visceral
fat depot of New Zealand Obese (NZO) mice, a model forlsevier B.V. All rights reserved.
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analyses, using preadipocytes and adipocytes, focussed on
two critical events in the hypothetical sequence of processes
involved in Hsp60-induced adipocyte activation: (1) the primary
interaction between Hsp60 and adipocytes was characterized
based on our previous ﬁndings demonstrating an Hsp60 receptor
structure on innate immune cells [11]; (2) the Hsp60-induced
release of adipocyte mediators was determined, as the decisive
event for the induction and/or progression of inﬂammatory
reactivity.
Our experiments demonstrate that Hsp60-adipocyte interac-
tions involve a receptor-mediated process and that Hsp60-induced
formation of proinﬂammatory mediators is largely independent of
the differentiation state of the adipocytes.2. Materials and methods
2.1. Mice and 3T3-L1 cells
NZO mice were obtained from the breeding colony at the Ger-
man Diabetes Center. The mouse preadipocyte line 3T3-L1 (ATCC,
Manassas, VA) was cultivated as described previously [4].
2.2. Isolation and differentiation of murine adipocytes
Murine preadipocytes were isolated from visceral adipose
tissue of six months old NZO mice by collagenase digestion [4].
3T3-L1 adipocytes were differentiated from preadipocytes as
described [12].
2.3. Oil-Red-O staining
Staining of adipocytes with the lipid-speciﬁc dye Oil-Red-O
(Sigma–Aldrich Chemie GmbH, Steinheim, Germany) was per-
formed as described previously [4].
2.4. FACS analyses
To prove the purity of the NZO mouse-derived adipocyte
preparation, cells were stained with an allophycocyanin-conju-
gated rat monoclonal antibody directed against the macrophage
marker CD11b (BD Biosciences, Heidelberg, Germany). The
expression of the maturation marker preadipocyte factor-1
(Pref-1) was determined using a FITC-conjugated rat anti-mouse
Pref-1 monoclonal antibody (MoBiTec, Göttingen, Germany) and
a FITC-conjugated rat anti-mouse IgG2a, K isotype control
(MoBiTec).
To investigate Hsp60 binding to adipocytes by FACS analysis,
human Hsp60 (Loke Diagnostics ApS, Aarhus, Denmark) was la-
beled with the ﬂuorescence dye Dylight649 (Perbio Science, Bonn,
Germany). Binding and inhibition studies were performed as de-
scribed previously [11]. The samples were analyzed by a FACSCal-
ibur ﬂow cytometer (BD Biosciences).
2.5. Western blot analysis
Lysates of adipocytes were separated by SDS–PAGE (10%) fol-
lowed by blotting onto a nitrocellulose membrane. Peroxisome
proliferator-activated receptor c (PPARc) was detected by sequen-
tial application of a rabbit anti-mouse PPARc antibody (Acris Anti-
body GmbH, Herford, Germany) and a peroxidase-conjugated goat
anti-rabbit antibody (SuperSignal West Femto-Kit, Pierce Thermo
Scientiﬁc, Bonn, Germany). The resulting chemiluminescence sig-
nals were visualized by a Lumi-Imager workstation (Roche Applied
Science, Mannheim, Germany).2.6. Quantiﬁcation of inﬂammatory mediators
To stimulate the production of inﬂammatory mediators, cells of
the adipocyte populations were exposed to different concentra-
tions of lipopolysaccharide (LPS, Escherichia coli O26:B6, Sigma–Al-
drich Chemie GmbH) or recombinant Hsp60 (Stressgen, Victoria,
BC, Canada) for 24 h. interleukin-6 (IL-6)-, mouse chemokine
CXCL1 (KC)- and monocyte chemoattractant protein-1 (MCP-1)-
concentrations accumulated in the supernatants were determined
by a multiplex beads system (Luminex Corp., Austin, TX) according
to the manufacturer’s instructions.
2.7. Statistical analysis
Data were expressed as means + S.D. Statistical analysis was
performed using the Student’s t-test. Differences were considered
statistically signiﬁcant with P < 0.05.3. Results
3.1. Characteristics of preadipocytes and differentiated adipocytes
The potential of Hsp60 to interact with adipocytes was studied
with cells of the 3T3-L1 line and with primary adipocytes isolated
from the visceral adipose tissue of NZO mice. The purity of the NZO
mouse-derived cell populations was conﬁrmed by FACS analyses
proving the absence of the macrophage-associated marker CD11b
(<1% CD11b+ cells) and by Oil-red-O staining, which revealed adi-
pocyte-speciﬁc lipid storage patterns in >99.2% of the cultivated
cells. The differentiation state of the adipocyte populations was
characterized by determining the expression levels of the matura-
tion markers Pref-1 and PPARc. As revealed by FACS analyses
Pref-1 expression declined from 97.4% in 3T3-L1 preadipocytes to
22.4% in differentiated 3T3-L1 cells (Fig. 1A and B). In NZO
mouse-derived adipocytes the expression of Pref-1 was reduced
from 76.7% to 12.8% during the differentiation process (Fig. 1C
and D). PPARc expression, as assessed by Western blot analyses,
was almost undetectable in 3T3-L1- or NZO mouse-derived preadi-
pocytes, but strongly increased in both cell populations after 14 d
of in vitro differentiation (data not shown).
3.2. Hsp60-induced release of inﬂammatory mediators from 3T3-L1
adipocytes
Based on our previous observations on the stimulatory effects of
Hsp60 on preadipocytes [4] we initially studied the potential of
Hsp60 to induce the release of inﬂammatory mediators from ter-
minally differentiated 3T3-L1 adipocytes. Exposure of 3T3-L1 adi-
pocytes to increasing concentrations of LPS and Hsp60 for 24 h
resulted in the dose-dependent accumulation of signiﬁcant
amounts of the inﬂammatory mediators IL-6, KC and MCP-1 in
the culture supernatants (Fig. 2). LPS (10 or 100 ng/ml), used as
an independent microbial stress signal with well known adipo-
cyte-stimulatory capacity, induced the accumulation of up to
1.6 ± 0.2 ng/ml IL-6, 9.5 ± 1.7 ng/ml KC and 8.4 ± 1.2 ng/ml MCP-
1. After exposure to Hsp60 (20 lg/ml) the cells also released con-
siderable amounts of IL-6 (1.2 ± 0.3 ng/ml), KC (7.5 ± 2.1 ng/ml)
and MCP-1 (8.1 ± 1.2 ng/ml) (Fig. 2A–C).
3.3. Responsiveness of NZO mouse-derived preadipocytes and
adipocytes
A potential impact of the differentiation state on the Hsp60
responsiveness of adipocytes was investigated by directly compar-
ing the reactivity of preadipocytes and differentiated adipocytes
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Fig. 2. Hsp60- and LPS-induced release of inﬂammatory mediators from 3T3-L1
adipocytes. Cells remained untreated (Medium control) or were exposed to LPS or
Hsp60 for 24 h. IL-6- (A), KC- (B) and MCP-1- (C) concentrations were determined
by multiplex beads assay. Data show means + S.D. from three independent
experiments each performed in triplicates. *P < 0.05; **P < 0.01; ***P < 0.001 com-
pared to the corresponding Medium control.
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LPS treatment induced the release of up to 17.2 ± 5.3 ng/ml IL-6,
87.5 ± 37.2 ng/ml KC and 41.3 ± 18.4 ng/ml MCP-1, whereas
Hsp60 stimulated the release of up to 7.5 ± 4.6 ng/ml IL-6,
41.4 ± 17.3 ng/ml KC and 28.5 ± 15.3 ng/ml MCP-1 (Fig. 3A–C). In
differentiated NZO mouse-derived adipocytes LPS induced the
release of up to 8.0 ± 6.1 ng/ml IL-6, 81.1 ± 17.8 ng/ml KC and
44.1 ± 23.2 ng/ml MCP-1, whereas Hsp60-treated cells released
up to 5.0 ± 5.3 ng/ml IL-6, 45.6 ± 14.3 ng/ml KC and 34.9 ± 17.8
ng/ml MCP-1 (Fig. 3A–C).
3.4. Interaction of Hsp60 with 3T3-L1 adipocytes
A ﬁrst approach to characterize potential Hsp60-adipocyte
interactions was performed in a FACS-based assay by the use of
3T3-L1 adipocytes and Hsp60 labeled with the ﬂuorochrome
Dylight649. Incubation of the cells with rising concentrations of
Hsp60-Dylight649 increased the mean ﬂuorescence signal, reach-
ing its maximum at an Hsp60 concentration of about 750 nM
(Fig. 4A). Preincubation with a 10-fold molar excess of unlabeled
Hsp60 inhibited the binding of Hsp60-Dylight649 (100 nM) to pre-
adipocytes by 82.4 ± 3.9% and to adipocytes by 43.4 ± 2.4%
(Fig. 4B). Potential unspeciﬁc protein effects on Hsp60-adipocyte
interactions were excluded by preincubation of the cells with a
10-fold molar excess of ovalbumin (OVA), which was without
effect on Hsp60 binding. Interestingly, binding of the ﬂuorescent-
labeled Hsp60 preparation (Loke Diagnostics ApS) could be inhib-
ited to a similar extend not only by the same Hsp60 preparation
(Loke Diagnostics ApS; 81.0 ± 10.9% inhibition), but also by an
Hsp60 preparation from a completely different source (Stressgen
Biotechnologies; 68.2 ± 9.2% inhibition) (Fig. 4C).
3.5. interaction with primary, NZO mouse-derived adipocytes
Finally, we investigated the interaction of Hsp60 with primary,
NZO mouse-derived preadipocytes and adipocytes (Fig. 5). Incuba-
tion of the cell populations with 100 nM of Hsp60-Dylight649
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Fig. 3. Hsp60- and LPS-induced release of inﬂammatory mediators from NZO
mouse-derived preadipocytes and adipocytes. Cells remained untreated (Medium
control) or were exposed to LPS or Hsp60 for 24 h. IL-6- (A), KC- (B) and MCP-1- (C)
concentrations were determined by multiplex beads assay. Data show means + S.D.
from three independent experiments each performed in triplicates. *P < 0.05;
**P < 0.01; ***P < 0.001 compared to the corresponding Medium control.
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tion with a 10-fold molar excess of unlabeled Hsp60 resulted in the
inhibition of Hsp60-Dylight649 binding to preadipocytes by
64.4 ± 8.1% and to adipocytes by 58.1 ± 14.5%, proving the speciﬁc-
ity of the Hsp60-adipocyte interaction. Pretreatment of the cells
with a 10-fold excess of OVA was without effect on Hsp60 binding,
thereby excluding potential unspeciﬁc protein effects on Hsp60-
adipocyte interactions.
4. Discussion
Adipocytes play a central role in the maintenance of metabolic
and immunological homeostasis [3]. Their pronounced triglyceride
storage capacity contributes to the stabilization of lipid metabo-
lism, whereas the stimulated release of immunologically active
mediators allows the cells to control low-grade inﬂammation
underlying many states of adiposity-related disorders including
insulin resistance and diabetes [13]. As the development of adipos-
ity is associated with progressive preadipocyte differentiation and
the vast expansion of the adipocyte population, the characteriza-
tion of signals modulating the activity of this cell population is of
central importance for our understanding of chronic inﬂammatory
processes observed in obese individuals.
Based on our recent observations, identifying the endogenous
stress signal Hsp60 as a potent stimulator of proinﬂammatory
activities of preadipocytes [4], the current study investigated the
potential effect of the differentiation process on the Hsp60-stimu-
lated release of inﬂammatory adipocyte mediators and on Hsp60binding, as the initial event in Hsp60-adipocyte interaction. Com-
parative approaches were performed with adipocyte populations
derived from the 3T3-L1-line or the NZO mouse, a model of human
E. Gülden et al. / FEBS Letters 583 (2009) 2877–2881 2881obesity and metabolic syndrome [10]. The purity of the cell popu-
lations was conﬁrmed by demonstrating adipocyte-typical lipid
distribution patterns and by proving the absence of CD11b, a mar-
ker for macrophages, which exhibit pronounced Hsp60 and LPS
responsiveness and are known to inﬁltrate adipose tissue [14,15].
The differentiation states of the adipocytes were conﬁrmed by
their speciﬁc expression patterns of the maturation markers PPARc
and Pref-1.
Hsp60 stimulated both preadipocytes and adipocytes to the
dose-dependent release of IL-6, KC and MCP-1 which were recently
identiﬁed as immune-mediators with central roles in obesity-asso-
ciated inﬂammatory processes [16,17]. Previous studies demon-
strated, that the proinﬂammatory stimulation of innate immune
cells by Hsp60 is mediated by LPS, speciﬁcally bound to a distinct
epitope of the stress protein [18]. Since adipocytes share many ba-
sic features with innate immune cells it could be speculated, that
the adipocyte-stimulatory principle of Hsp60 also involves specif-
ically bound LPS. Interestingly, the exclusive addition of LPS to the
cells, induced the formation of similar patterns of inﬂammatory
mediators in both adipocyte populations, thereby conﬁrming re-
cent ﬁndings on the LPS responsiveness of adipocytes [19].
The observation of an Hsp60-induced release of inﬂammatory
mediators from adipocytes suggests a speciﬁc interaction of the
cells with this stress protein. Adipocytes possess receptor struc-
tures which exhibit different expression patterns dependent on
the differentiation state and allow the cells to respond to various
signaling molecules including insulin and insulin-like growth fac-
tor-1 [20]. Based on our previous observations, demonstrating an
Hsp60 receptor structure on macrophages [10], we tested the
hypothesis, that Hsp60-adipocyte interactions involve a receptor-
mediated process. A FACS-based assay revealed a concentration-
dependent increase of binding of ﬂuorescent-labeled Hsp60 to adi-
pocytes that reached its maximum at about 750 nM and could be
inhibited by unlabeled Hsp60 but not by unrelated proteins. Pre-
adipocytes and adipocytes exhibited similar characteristics of
Hsp60 binding and inhibition. Hsp60 binding, as the critical event
in the initiation of adipocyte stimulation, could potentially be af-
fected by preparation-speciﬁc structural modiﬁcations of the stress
protein (e.g. partial misfolding) or by the presence of other compo-
nents (e.g. Hsp60 fragments) interfering with proper Hsp60 recep-
tor interaction. However, our ﬁnding that binding of ﬂuorescent-
labeled Hsp60 could be inhibited to a similar high extend by
Hsp60 preparations from two different sources largely rules out
any preparation-speciﬁc effects and clearly points to Hsp60 as
the mediator of the observed biological effects. Taken together,
our ﬁndings of Hsp60-adipocyte interactions implicate the pres-
ence of an Hsp60 receptor on adipocytes. However, further detailed
characterization of the receptor will require extensive additional
studies which may pursue our previously developed concept of
an Hsp60 receptor structure that consists of at least two function-
ally different components for Hsp60-binding and -signaling [6,10].
Our ﬁndings of comparable Hsp60 binding and Hsp60-induced
release of inﬂammatory mediators in preadipocytes and adipocytes
identify Hsp60 responsiveness as a basic functional property of
adipocytes that is largely independent of their differentiation state.
However, as differentiated adipocytes constitute by far the largest
adipocyte population in the adipose tissue of obese individuals,this cell fraction has to be considered as a relevant source of
Hsp60-induced mediators which may contribute to adiposity-asso-
ciated proinﬂammatory conditions.Acknowledgements
We thank Jutta Brüggemann and Ulrike Wohlrab for excellent
technical assistance. This work was supported by the Bundesmin-
ister für Gesundheit, by the Minister für Innovation, Wissenschaft,
Forschung und Technologie des Landes Nordrhein-Westfalen,
by the Deutsche Diabetes-Gesellschaft and by the Deutsche
Forschungsgemeinschaft.References
[1] Charrière, G., Cousin, B., Arnaud, E., André, M., Bacou, F., Pénicaud, L. and
Casteilla, L. (2003) Preadipocyte conversion to macrophage. Evidence of
plasticity. J. Biol. Chem. 278, 9850–9855.
[2] Fantuzzi, G. (2005) Adipose tissue, adipokines, and inﬂammation. J. Allergy
Clin. Immunol. 115, 911–919.
[3] Wellen, K.E. and Hotamisligil, G.S. (2005) Inﬂammation, stress, and diabetes. J.
Clin. Invest. 115, 1111–1119.
[4] Gülden, E., Mollérus, S., Brüggemann, J., Burkart, V. and Habich, C. (2008) Heat
shock protein 60 induces inﬂammatory mediators in mouse adipocytes. FEBS
Lett. 582, 2731–2736.
[5] Fink, A.L. (1999) Chaperone-mediated protein folding. Physiol. Rev. 79, 425–
449.
[6] Habich, C. and Burkart, V. (2007) Heat shock protein 60: regulatory role on
innate immune cells. Cell. Mol. Life Sci. 64, 742–751.
[7] Avram, M.M., Avram, A.S. and James, W.D. (2007) Subcutaneous fat in normal
and diseased states 3. Adipogenesis: from stem cell to fat cell. J. Am. Acad.
Dermatol. 56, 472–492.
[8] Wada, T., Shimba, S. and Tezuka, M. (2006) Transcriptional regulation of the
hypoxia inducible factor-2alpha (HIF-2alpha) gene during adipose
differentiation in 3T3-L1 cells. Biol. Pharm. Bull. 29, 49–54.
[9] Hauner, H. (2005) Secretory factors from human adipose tissue and their
functional role. Proc. Nutr. Soc. 64, 163–169.
[10] Macaulay, S.L. and Larkins, R.G. (1988) Impaired insulin action in adipocytes of
New Zealand obese mice: a role for postbinding defects in pyruvate
dehydrogenase and insulin mediator activity. Metabolism 37, 958–
965.
[11] Habich, C., Baumgart, K., Kolb, H. and Burkart, V. (2002) The receptor for heat
shock protein 60 on macrophages is saturable, speciﬁc, and distinct from
receptors for other heat shock proteins. J. Immunol. 168, 569–576.
[12] Student, A.K., Hsu, R.Y. and Lane, M.D. (1980) Induction of fatty acid
synthetase synthesis in differentiating 3T3-L1 preadipocytes. J. Biol. Chem.
255, 4745–4750.
[13] Hotamisligil, G.S. (2006) Inﬂammation and metabolic disorders. Nature 444,
860–867.
[14] Chen, W., Syldath, U., Bellmann, K., Burkart, V. and Kolb, H. (1999) Human 60-
kDa heat-shock protein: a danger signal to the innate immune system. J.
Immunol. 162, 3212–3219.
[15] Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. and Ferrante,
A.W. (2003) Obesity is associated with macrophage accumulation in adipose
tissue. J. Clin. Invest. 112, 1796–1808.
[16] Bastard, J.P., Maachi, M., Lagathu, C., Kim, M.J., Caron, M., Vidal, H., Capeau, J.
and Feve, B. (2006) Recent advances in the relationship between obesity,
inﬂammation, and insulin resistance. Eur. Cytokine Netw. 17, 4–12.
[17] de Ferranti, S. and Mozaffarian, D. (2008) The perfect storm: obesity, adipocyte
dysfunction, and metabolic consequences. Clin. Chem. 54, 945–955.
[18] Habich, C., Kempe, K., van der Zee, R., Rümenapf, R., Akiyama, H., Kolb, H. and
Burkart, V. (2005) Heat shock protein 60: Speciﬁc binding of
lipopolysaccharide. J. Immunol. 174, 1298–1305.
[19] Hoch, M., Eberle, A.N., Peterli, R., Peters, T., Seboek, D., Keller, U., Müller, B. and
Linscheid, P. (2008) LPS induces interleukin-6 and interleukin-8 but not tumor
necrosis factor-alpha in human adipocytes. Cytokine 41, 29–37.
[20] Bäck, K. and Arnqvist, H.J. (2009) Changes in insulin and IGF-I receptor
expression during differentiation of human preadipocytes. Growth Horm. IGF
Res. 19, 101–111.
